2 Biosimilars Make Their Way Toward the European Market
- Tweet
You Might Also Like:
- Samsung Bioepis Receives Final European Approval for Its Remicade Copy
- Biosimilars Seek Regulatory Approval in the U.S. & Europe; Plus MTX Underused in the U.S.
- As Biosimilars Hit, EU Pharma Warns against Blanket Prescribing
- Biosimilars Update: FDA Panel Voted to Approve Biosimilars for Etanercept & Adalimumab at July Meeting